SUBLIMITY THERAPEUTICS
Sublimity Therapeutics (formerly Sigmoid Pharma), is a specialty pharma company with offices in Dublin, Ireland, and Solana Beach, California. Sublimity’s goal is to identify and create meaningful new therapies for unmet clinical needs in gastrointestinal and immunological diseases. Sublimity’s priority focus is on its lead product, STI-0529, for treatment of moderate to severe ulcerative colitis.
SUBLIMITY THERAPEUTICS
Social Links:
Industry:
Biotechnology Delivery Health Care Pharmaceutical Wellness
Founded:
2000-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.sublimitytherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
(353) 170-0751
Email Addresses:
[email protected]
Total Funding:
70.34 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API WordPress Font Awesome Organization Schema Sitelinks Search Box WordPress 5.2 All In One SEO Pack
Similar Organizations
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-02-16 | Freund Pharmatec | Freund Pharmatec acquired by Sublimity Therapeutics | N/A |
Investors List
HBM Healthcare Investments
HBM Healthcare Investments investment in Series B - Sublimity Therapeutics
HBM Healthcare Investments
HBM Healthcare Investments investment in Venture Round - Sublimity Therapeutics
Longitude Capital
Longitude Capital investment in Venture Round - Sublimity Therapeutics
OrbiMed
OrbiMed investment in Venture Round - Sublimity Therapeutics
Pendopharm
Pendopharm investment in Venture Round - Sublimity Therapeutics
Official Site Inspections
http://www.sublimitytherapeutics.com Semrush global rank: 8.33 M Semrush visits lastest month: 570
- Host name: 172.67.217.218
- IP address: 172.67.217.218
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sublimity Therapeutics"
Sublimity Therapeutics Company Profile 2024: …
Sublimity Therapeutics was founded in 2003. Where is Sublimity Therapeutics headquartered? Sublimity Therapeutics is headquartered in Dublin, Ireland. What is the size of Sublimity Therapeutics? Sublimity Therapeutics has 50 total …See details»
Sublimity Therapeutics - VentureRadar
"Sublimity is a clinical stage biopharmaceutical company leveraging our proprietary SmPill platform technology to develop a pipeline of novel oral therapeutics for inflammatory bowel …See details»
Sublimity Therapeutics Company Profile | Management and
Sublimity Therapeutics Profile and History Sublimity Therapeutics is a specialty pharma company with offices in Dublin, Ireland, and Solana Beach, California. Sublimity's goal is to identify and …See details»
Sublimity Therapeutics Overview | SignalHire Company Profile
Sublimity Therapeutics is a private company that has been in the industry for 23 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals areas. ... Organization …See details»
Sublimity Therapeutics: Contact Details and Business Profile
Sublimity Therapeutics is a clinical-stage biotechnology company dedicated to identifying and developing meaningful new therapies for unmet clinical needs in gastrointestinal and …See details»
SUBLIMITY THERAPEUTICS INC. - Dun & Bradstreet
Sublimity therapeutics inc. d&b business directory home / business directory / manufacturing / chemical manufacturing / pharmaceutical and medicine manufacturing / united states / …See details»
Sublimity Therapeutics Company Profile - Craft
Sublimity Therapeutics is a biotechnology company dedicated to identifying and creating therapies for clinical needs in gastrointestinal and immunological diseases. It develops SmPill …See details»
Organization | Sublimity Therapeutics
Organization Overview. First Clinical Trial. 2010 NCT01033305. First Marketed Drug. None First NDA Approval. None ... Sublimity Therapeutics (HoldCo) Ltd Active Ingredients. Drugs in …See details»
Sublimity Therapeutics Ltd - Company Profile and News
Sublimity Therapeutics Ltd. Sigmoid Pharma Ltd., is a biopharmaceutical development company. The Company develops pharmaceutical products in the areas of transplantation, gastro …See details»
Sublimity Therapeutics - Overview, News & Similar companies
Feb 27, 2020 Sublimity Therapeutics is a specialty pharma company with offices in Dublin, Ireland, and Solana Beach, California. Sublimity's goal is to identify and create meaningful …See details»
Sublimity Therapeutics - LinkedIn
Sublimity Therapeutics is a clinical-stage biotechnology company dedicated to identifying and developing meaningful new therapies for unmet clinical needs in gastrointestinal and …See details»
Sublimity Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Sublimity Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified …See details»
Sublimity Therapeutics | VentureRadar
Find out more about Sublimity Therapeutics, Biotechnology, Biotech, Delivery platform and Biopharmaceutical. All; Ranked; Organisation Names; Apps and Links. Homepage (myVR) …See details»
Sublimity Therapeutics - Tech Company Profile - Gaebler.com …
Sublimity Therapeutics is a specialty pharma company with offices in Dublin, Ireland, and Solana Beach, California. Sublimity's goal is to identify and create meaningful new therapies for unmet …See details»
Sublimity Therapeutics - Funding, Financials, Valuation & Investors
Sublimity Therapeutics is funded by 4 investors. HBM Healthcare Investments and HBM Healthcare Investments are the most recent investors. Sublimity Therapeutics has acquired …See details»
Sublimity Therapeutics CEO and Key Executive Team | Craft.co
Sublimity Therapeutics's Board Member is Alexander Asam. Other executives include Albert Agro, President and Chief Executive Officer and Director; Anthony J. Giovinazzo, Executive …See details»
Sublimity Therapeutics - Contacts, Employees, Board Members, …
Organization. Sublimity Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... About. Sublimity Therapeutics has 3 current employee …See details»
Sublimity To Present at Three Life science Investment
Feb 27, 2020 Investors: Albert Agro President & CEO Sublimity Therapeutics Ph: +1-858-952-2577 [email protected]: Media: Bob Butler VP Corporate …See details»